[1] | Tachedjian G, Aldunate M, Bradshaw CS, Cone RA. The role of lactic acid production by probioticLactobacillusspecies in vaginal health. Res Microbiol. 2017; 168: 782-792. doi:10.1016/j.resmic.2017.04.001. |
[2] | Lamont RF, Sobel JD, Akins RA, Hassan SS, Chaiworapongsa T, Kusanovic JP, et al. The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG. 2011; 118: 533-549. doi:10.1111/j.1471-0528.2010.02840.x. |
[3] | Mendes-Soares H, Suzuki H, Hickey RJ, Forney LJ. Comparative functional genomics of Lactobacillus spp. Reveals possible mechanisms for spezialization of vaginal lactobacilli to their environment. Journal of Bacteriology. 2014; 196: 1458-1470. doi:10.1128/JB.01439-13. |
[4] | Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA. 2011; 108: 4680-4687. doi:10.1073/pnas.1002611107. |
[5] | Budilovskaya OV, Shipitsyna EV, Gerasimova EN, et al. Species diversity of vaginal lactobacilli in norm and in dysbiotic states. Journal of Obstetrics and Women’s Diseases. 2017; 66(2): 24-32 [in Russ]. doi:10.17816/JOWD66224-32. |
[6] | Jespers V, van de Wijgert J, Cools P, et al. The significance of Lactobacillus crispatus and Lactobacillus vaginalis for vaginal health and the negative effect of recent sex: a cross-sectional descriptive study across groups of African women. BMC Infect Dis. 2015; 15: 115. doi:10.1186/s12879-015-0825-z. |
[7] | Dols JA, Molenaar D, van der Helm JJ, et al. Molecular assessment of bacterial vaginosis by Lactobacillus abundance and species diversity. BMC Infect Dis. 2016; 16: 180. doi:10.1186/s12879-016-1513-3. |
[8] | Nazarova VV, Shipitsyna EV, Shalepo KV, Savicheva AM. Bacterial communities forming the vaginal microecosystem in norm and in bacterial vaginosis. Journal of Obstetrics and Women’s Diseases. 2017; 66(6): 30-43 [in Russ]. doi:10.17816/JOWD66630-43. |
[9] | Mendling W, Palmeira‑de‑Oliveira A, Biber S, Prasauskas V. An update on the role of Atopobiumvaginae in bacterial vaginosis: what to consider when choosing a treatment? A mini review Archives of Gynecology and Obstetrics. 2019; 300:1–6. doi:10.1007/s00404-019-05142-8. |
[10] | Gajer P, Brotman RM, Bai G, Sakamoto J, Schütte UM, Zhong X, et al. Temporal dynamics of the human vaginal microbiota. Sci Transl Med. 2012; 4(132): 132-152. doi:10.1126/scitranslmed.3003605. |
[11] | Gladysheva IV, Cherkasov SV. Corinebacteria of vaginal microbiom – potential pathogens or perspective probiotcs? Bulletin of the Orenburg scientific center of the Ural branch of the Russian Academy of Sciences. 2019; 3: 1-20. [in Russ]. doi:10.24411/2304-9081-2019-130225. |
[12] | Torcia MG. Interplay among vaginal microbiome, immune response and sexually transmitted viral infections. Int J Mol Sci. 2019; 20: E266. doi:10.3390/ijms20020266. |
[13] | Macklaim JM, Fernandes AD, Di Bella JM, Hammond J, Reid G, Gloor GB. Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis. Microbiome. 2013; 1: 12. doi:10.1186/2049-2618-1-12. |
[14] | Sobel JD, Kaur N, Woznicki NA, Boikov D, Aguin T, Gill G, Akins RA. Prognostic indicators of recurrence of bacterial vaginosis. J Clin Microbiol. 2019; 57: e00227-19. doi:10.1128/JCM.00227-19. |
[15] | Campisciano G., Zanotta N, Licastro D, De Seta F, Comar M. In vivo microbiome and associated immune markers: new insights into the pathogenesis of vaginal dysbiosis. Sci Rep. 2018; 8: 2307. doi:10.1038/s41598-018-20649-x. |
[16] | Melkumyan AR, Priputnevich TV, Ankirskaya AS, et al. Species composition of lactobacilli in different States of the vaginal microbiota in pregnant women. Clinical Microbiology and antimicrobial chemotherapy. 2013; 15(1): 72–79 [inRuss]. |
[17] | Shishkova YuS, Dolgushina VF, Grafova ED, et al. Biofilm formation in lactobacilli isolated from the reproductive tract of women in the first trimester of pregnancy. Bulletin of modern clinical medicine. 2016; 9(5): 53-56 [in Russ]. doi:10.20969/VSKM.2016.9(5).53-56. |
[18] | Burmenskaya OV, Bayramova GR, Nepsha OS, et al. Species composition of lactobacilli in non-specific vaginitis and bacterial vaginosis and its effect on local immunity. Obstetrics and gynecology. 2014; 1: 41–45 [in Russ]. |
[19] | O’Hanlon DE, Moench TR, Cone RA. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota. PLoS One. 2013: 8; e80074. doi.10.1371/journal.pone.0080074. |
[20] | Linhares IM, Summers PR, Larsen B, et al. Contemporary perspectives on vaginal pH and lactobacilli. Am J Obstet Gynecol. 2011; 204(2): 120.e1-5. doi:10.1016/j.ajog.2010.07.010. |
[21] | Witkin SS, Mendes-Soares H, Linhares IM, et al. Influence of vaginal bacteria andD- andL-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections. mBio. 2013; 4(4): e00460-13. doi:10.1128/mBio.00460-13. |
[22] | Rizzo A, Losacco A, Carratelli CR. Lactobacillus crispatus modulates epithelial cell defense against Candida albicans through Toll-like receptors 2 and 4, interleukin 8 and human beta-defensins 2 and 3. Immunol Lett. 2013; 156(1-2): 102-109. doi:10.1016/j.imlet.2013.08.013. |
[23] | Ghartey JP,Smith BC, Chen Z, Buckley N, Lo Y, Ratner AJ, et al. Lactobacillus crispatus dominant vaginal microbiome is associated with inhibitory activity of female genital tract secretions against Escherichia coli. PLoS ONE. 2014; 9(5): e96659.doi:10.1371/journal.pone.0096659. |
[24] | De Seta F, Campisciano G, Zanotta N, Ricci G, Comar M. The Vaginal Community State Types Microbiome-Immune Network as Key Factor for Bacterial Vaginosis and Aerobic Vaginitis. Front Microbiol. 2019; 10: 2451. doi:10.3389/fmicb.2019.02451. |
[25] | Stafford GP, Parker JL, Amabebe E, et al. Spontaneous preterm birth is associated with differential expression of vaginal metabolites by Lactobacilli-dominated microflora. Front Physiol. 2017; 8: 615. doi:10.3389/fphys.2017.00615. |
[26] | Kalyoussef S, Nieves E, Dinerman E, et al. Lactobacillus proteins are associated with the bactericidal activity against E.coli of female genital tract secretions. PLoS ONE. 2012; 7: e49506. doi:10.1371/journal.pone.0049506. |
[27] | Aldunate M, Srbinovski D, Hearps AC, et al. Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis. Front Physiol. 2015; 6: 164. doi:10.3389/fphys.2015.00164. |
[28] | Hardy L, Cerca N, Jespers V, et al. Bacterial biofilms in the vagina. Res Microbiol. 2017; 168(9-10): 865-874. doi:10.1016/j.resmic.2017.02.001. |
[29] | Liu MB, Xu SR, He Y, Deng GH, Sheng HF, et al. Diverse vaginal microbiomes in reproductive-age women with vulvovaginal candidiasis. PLoS ONE. 2013; 8(11): e79812. doi:10.1371/journal.pone.0079812. |
[30] | Сrann SE, Cunningham S, Albert A, et al. Vaginal health and hygiene practices and product use in Canada: a national cross-sectional survey. BMC Womens Health. 2018; 18: 52. doi:10.1186/s12905-018-0543-y. |
[31] | Rakhmatullaeva MM. Treatment of bacterial vaginosis: problems and prospects. Pharmateca. 2019; 26(6): 79-83 [in Russ]. doi:10.18565/pharmateca.2019.6.79-83. |
[32] | Hilbert DW, Smith WL, Paulish-Miller TE, et al. Utilization of molecular methods to identify prognostic markers for recurrent bacterial vaginosis. Diagn Microbiol Infect Dis. 2016; 86: 231-242. doi:10.1016/j.diagmicrobio.2016.07.003. |